Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zymeworks (ZYME) EPS (Weighted Average and Diluted) (2021 - 2025)

Zymeworks' EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.55 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 71.87% to -$0.55 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.08, a 33.33% increase, with the full-year FY2025 number at -$1.08, up 33.33% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.55 in Q4 2025 for Zymeworks, down from -$0.26 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for ZYME hit a ceiling of $4.76 in Q4 2022 and a floor of -$1.25 in Q3 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.26 across 5 years, with a median of -$0.42 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 601.05% in 2022 and later tumbled 103.99% in 2023.
  • Tracing ZYME's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.95 in 2021, then soared by 601.05% to $4.76 in 2022, then tumbled by 103.99% to -$0.19 in 2023, then plummeted by 68.42% to -$0.32 in 2024, then tumbled by 71.87% to -$0.55 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ZYME at -$0.55 in Q4 2025, -$0.26 in Q3 2025, and $0.03 in Q2 2025.